title: Effects of angiotensin converting enzyme inhibitor and angiotensin II analogue on hypertension. Study of hypertension with two different blockers of the renin-angiotensin-aldosterone system.
authors.forename: K
authors.initials: K
authors.lastname: Kodama
authors.forename: Y
authors.initials: Y
authors.lastname: Morotomi
authors.forename: O
authors.initials: O
authors.lastname: Kida
authors.forename: T
authors.initials: T
authors.lastname: Higa
authors.forename: N
authors.initials: N
authors.lastname: Someya
authors.forename: K
authors.initials: K
authors.lastname: Kondo
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
mesh_terms: D015059:1-Sarcosine-8-Isoleucine Angiotensin II / Q000627:therapeutic use; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D012084:Renin-Angiotensin System / Q000187:drug effects; D013722:Teprotide
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D009842:Oligopeptides; D015059:1-Sarcosine-8-Isoleucine Angiotensin II; D002216:Captopril; D013722:Teprotide